lichenoid vulvar disease
Conditions
Interventions
Sponsors
West China Second Hospital of Sichuan University
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Inclusion Criteria: 1. Patients with a confirmed clinical and/or pathological biopsy diagnosis of VLD; 2. No relevant treatment received in the past two weeks; 3. Complete clinical and pathological data, with follow-up compliance; 4. Willingness to participate in the study and signed informed consent.
Exclusion criteria
Exclusion criteria: Exclusion Criteria: 1. History of protein allergy; 2. Acute inflammatory phase of the genitourinary system; 3. Presence of hematologic disorders, immune dysfunction, or malignancies; 4. Pregnancy; 5. Severe systemic medical conditions affecting daily life (e.g., diagnosed severe cardiovascular diseases or immune system disorders); 6. Psychological or psychiatric disorders (e.g., depression) that prevent completion of follow-up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Treatment efficacy rate;Degree of symptom improvement;Dermatology Life Quality Index (DLQI); | — |
Secondary
| Measure | Time frame |
|---|---|
| Subjective patient satisfaction;Incidence of adverse reactions; | — |
Countries
China
Contacts
Public ContactWei Dongmei
West China Second Hospital of Sichuan University
Outcome results
None listed